The influence of old age in humans on the metabolism of drugs and other compounds that undergo phase I, phase II, capacity-limited and flow-limited metabolism
Hepatic Metabolism | Reduced | Percentage of Change | Unchanged | Percentage of Change |
---|---|---|---|---|
Flow-limited | Indocyanine green | −35*, −60* | ||
Pethidine | −44*, +12 | |||
Morphine | −18*, −35*, −16 | |||
Propranolol | −51, −41*, −30*, −24* | |||
Amitriptyline | −62*, −14 | |||
Verapamil | −32*, −42 | |||
Imipramine | −45* | |||
Lignocaine | +7, −35*, −6 | |||
Capacity-limited | Theophylline | −22*, −33*, −15, +33, +17, −15, nonsmoker −35*, −33*, +11, −31* | Diazepam | −3, male −39*, −48*, female −6, −17 |
Antipyrine | −20*, −42*, +32, −39*, −52*, −51*, +32, −33* | Digitoxin | +20 | |
Phenytoin | +62*, +4 | |||
Salicylic acid | −7, +4, −29 | |||
Valproic acid | 0, −16, 0 | |||
Warfarin | +25, −25, 0 | |||
Phase I | Antipyrine | −20*, −42*, +32, −39*, −52*, −51*, +32, −33* | Warfarin | −25, −25, 0 |
Chlormethiazole | −84*, −30* | Caffeine | +13 | |
Diltiazem | −7, −39* | Phenytoin | +62*, +4 | |
Propranolol | −51, −41*, −30*, −24* | |||
Theophylline | −22*, −33*, −15, +33, +17, −15, nonsmoker −35*, −33*, +11, −31* | |||
Imipramine | −45* | |||
Amitriptyline | −62*, −14 | |||
Verapamil | −32*, −42 | |||
Ibuprofen | −16*, +12 | |||
Lignocaine | +7, −35*, −6 | |||
Phase II | Morphine | −18*, −35*, −16 | Isoniazid | rapid acetylator + 13, −13 slow acetylator −1, −22 |
Oxazepam | +20 | |||
Paracetamol | −35*, −21, −25*, −34*, −23, −19*, −8 | |||
Salicylic acid | −7, +4, −29 | |||
Temazepam | male −1, female −12 |
↵* Statistically significant; −, decrease; +, increase (Le Couteur and McLean, 1998).